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ABSTRACT  
 
Acanthocytic red blood cells (RBCs) are a peculiar diagnostic feature of chorea-
acanthocytosis (ChAc), a rare autosomal recessive neurodegenerative disorder. Although 
recent years have witnessed some progress in the molecular characterization of ChAc, the 
mechanism(s) responsible for generation of acanthocytes in ChAc is largely unknown. As 
the membrane protein composition of ChAc RBCs is similar to that of normal RBCs, we 
evaluated the tyrosine-(Tyr)-phosphorylation profile of RBCs using comparative 
proteomics. Increased Tyr-phosphorylation state of several membrane proteins including 
band 3, beta-spectrin and adducin was noted in ChAc RBCs. In particular, band 3 was 
highly phosphorylated on the Tyr-904 residue, a functional target of Lyn, but not on Tyr-8, 
a functional target of Syk. In ChAc RBCs band 3 Tyr-phosphorylation by Lyn was 
independent of the canonical Syk mediated pathway. The ChAc-associated alterations in 
RBC-membrane-protein organization appear to be the result of increased Tyr-
phosphorylation leading to altered linkage of band 3 to the junctional complexes involved 
in anchoring the membrane to the cytoskeleton as supported by co-immunoprecipitation of 
β-adducin with band 3 only in ChAc RBC-membrane treated with the Lyn-inhibitor PP2. 
We propose this altered association between membrane skeleton and membrane proteins 
as novel mechanism in the generation of acanthocytes in ChAc. 
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INTRODUCTION  
 
Chorea-acanthocytosis (ChAc) is a rare autosomal recessive neurodegenerative disorder 
of the neuroacanthocytosis (NA) group. 1-3 ChAc is characterized by a neurodegeneration 
syndrome of the basal ganglia that is associated with the presence of acanthocytes, 
abnormal erythrocytes with thorn-like protrusions, in the peripheral circulation. 1-3  
Molecular studies have identified mutation(s) of the VPS13A gene (chromosome 9), 
encoding a 360 kDa protein chorein of unknown function that is ubiquitously expressed in 
the brain. 2,4-6 To date 92 mutations on the VPS13A gene have been reported, resulting in 
low or absent synthesis of chorein or in expression of a functionally defective protein at 
normal levels. 2,4-6 Chorein has been detected in mature red cells but it is partially or 
completely absent in red cells from patients with ChAc. 6 Due to the lack of knowledge on 
the structure of chorein and on its interaction with other proteins, we can only speculate on 
the role of chorein in red cell homeostasis.  
In the red cell membrane two major multiprotein complexes bridge the lipid bilayer with the 
integral membrane proteins to the spectrin-actin cytoskeleton: the ankyrin complex and the 
junctional or 4.1R complex.7 Electron microscopy of ChAc red cells reveals ultrastructural 
abnormalities in the membrane skeleton as indicated by a heterogeneous distribution of 
the cytoskeleton. Condensed skeletal structures around protrusions and a less filamentous 
structure in some large membrane patches indicate a perturbation of membrane 
cytoskeleton network associated with the membrane protrusions that characterize 
acanthocytes.8 These structural data were also supported by the observation that ChAc 
patients have a fraction of dense red cells containing acanthocytes with a reduced cell K+ 
content compared to normal controls.9 Red cells from ChAc patients did not show overall 
abnormalities in red cell membrane protein composition and content; although there is 
accumulating evidence for neuroacanthocytosis-specific abnormalities in band 3 structure 
and function.10 Increased membrane serine-threonine phosphorylation levels mainly of 
band 3 and spectrin, increased levels of band 3 tyrosine phosphorylation and increased 
activity of membrane associated casein-kinase have also been described in ChAc red 
cells.11 Increased amount of Nε (γ-glutamyl) lysine isopeptides associated with the red cell 
membrane has also been reported in a few ChAc patients, indicating a possible 
perturbation of the anchoring bridges between the membrane and the cytoskeleton.12,13  
There is no consistent data indicating a relation between lipid content and/or composition 
and acanthocytosis in ChAc patients.  
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The recent development of proteomic techniques has yielded a description of red cell 
membrane proteome mainly in normal red cells.14-18 We used comparative proteomics to 
study membrane proteome of red cells from patients with ChAc in relation to normal 
controls. Differences between normal and ChAc red cells included changes in tyrosine 
phosphorylation state of band 3, beta spectrin and other members of the anchoring 
complexes in ChAc red cells. We also found abnormal activation of Lyn, a Tyr-kinase of 
the Src family, independent from its canonical signaling pathway involving primary 
phosphorylation of Syk. These finding suggest that altered phosphorylation of band 3 and 
membrane skeletal proteins may play a role in the development of acanthocyte 
morphology in chorea-acanthocytosis.  
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MATERIALS AND METHODS 
 
Design of the study. 
We studied nine patients with chorea-acanthocytosis (ChAc) based on clinical neurological 
manifestations, presence of acanthocytes (Fig. 1a) and confirmation by either immunoblot 
analysis for chorein and/or molecular analysis for VPS13A mutations as previously 
described.6  The demographic and molecular data of patients are reported in Table 1. 
Blood was obtained by venipuncture using EDTA as an anti-coagulant, according to the 
guidelines approved by the local Ethics Committees for human subject studies of all 
participating institutions involved. Blood samples ( ChAc patients and healthy control 
donors) were shipped to Verona and Nijmegen at 4°C, and processed immediately after 
arrival. Erythrocytes were isolated from whole blood after removal of white blood cells and 
platelets as previously described.19  Since ChAc patients  have a dense fraction of red 
cells enriched in acanthocytes,9 we analyzed red cells separately according to red cell 
density.  
For semi-quantitative proteome analyses, we separated the red cells in one of two ways. 
Cells were separated into five fractions  (I-V) based on volume and density using counter 
flow centrifugation followed by Percoll gradient centrifugation, with fraction I containing the 
youngest, and fraction V the oldest erythrocytes and acanthocytes. The membrane 
proteomes of these fractions were analyzed as described previously.15  
Alternatively, red cells were separated into two fractions: fraction 1 (F1) corresponding to a 
density < 1.074, containing reticulocytes, and fraction 2 (F2) corresponding to a density > 
1.092, containing acanthocytes, for proteomic analysis by 2DE-MALDI-TOF MS, which 
requires a relatively large amount of proteins for the analysis.19,20 Where indicated control 
red cells were incubated in the presence of sodium orthovanadate as previously described 
by Bordin et al.21 
Red cell morphology, membrane preparation and membrane cytoskeleton extraction  
To study cell morphology, red cells were fixed as previously described by Matte et al.22 
and imaged using a Leica TCS SP5 II microscope equipped with an Objective HCX PL 
APO lambda blue 63.0x, NA 1.40 oil.  
Red cell membrane fractions were obtained by lysing one volume of packed cells in 10 
volumes of ice-cold phosphate lysis buffer (PLB, 5 mM Na2HPO4 pH 8.0, in the presence 
of protease inhibitors (cocktail tablet, Roche; Germany), 3 mM benzamidine, 1 mM 
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Na3VO4). Samples were incubated for 10 min on ice and centrifuged for 10 min at 12,000 x 
g at 4°C. Membranes were then washed four times by centrifugation at 12,000 x g at 4°C 
with PLB until they appeared almost white.15 
To assess the strength of the interaction between cytoskeleton and the lipid bilayer, 
cytoskeletal proteins were extracted by resuspending membranes (100 µg of total protein) 
in one ml of 100 mM Na2CO3 pH 11. The suspension was passed five times through a 25-
gauge needle, mixed and incubated for 30 min at 4°C. Soluble proteins were removed by 
centrifugation for 30 min at 200,000 x g. This procedure was repeated twice. Proteins from 
pelletted membranes were extracted by either detergent or NaCl. Briefly, packed 
erythrocyte membranes were incubated for 1 hour at 4°C with 50 mM Tris-HCl, pH 7.5, 
10% glycerol, 1 mM sodium orthovanadate, and protease inhibitor cocktail in the absence 
or the presence of either 1% Triton X-100 22 or 0.6 M NaCl. After ultracentrifugation, the 
supernatants and precipitates were analysed by one-dimensional electrophoresis and 
either stained with colloidal Coomassie or transferred to membranes for immunoblot 
analysis with the appropriate antibody.22  
Comparative proteomic analysis 
Semi-quantitative proteomic analysis. All the analyses were performed essentially as 
previously described.15 Details are reported in Supplementary Methods section. Samples 
of various origins were quantified by the label-free peptide counting method emPAI, that 
calculates protein abundancy, as has been applied for a quantitative analysis of RBC 
membranes during storage.15 Data were normalized using the median emPAI value per 
sample. This protocol has been shown to result in a reliable identification of all erythrocyte 
membrane proteins, and to enable semi-quantification of the major protein species.15 In 
order to be able to apply this method to multiple samples in an efficient and cost-effective 
manner, we reduced the running time of the SDS-PAGE step and extended the running 
time of the HPLC gradient from 1.5 to 4 hours. This ‘one-slice’ method yielded 300-400 
reliably identified proteins, comparable to those found earlier by us and others using one-
dimensional as well as two-dimensional electrophoresis.15,23,24 
Gel electrophoresis of red cells membrane. For one-dimensional electrophoresis (1DE), 
red cell membranes were solubilized in sample buffer (50 mM Tris pH 6.8, 100 mM β-
mercaptoethanol, 2% v/v SDS, 10% v/v glycerol, a few grains of bromophenol blue), and 
loaded on to either 8 % or 10 % polyacrylamide gels. Whenever peroxiredoxin-2 (Prx-2) 
was evaluated, red cells were lysed in the presence of NEM (100 mM) in the PLB and 
solubilized in sample buffer with NEM (100 mM).19,20,22 For two-dimensional 
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electrophoresis (2DE), red cell membranes were delipidated and separated by 2DE as 
previously described. 19,20,22 Details are presented in Supplementary Methods section After 
electrophoresis the gels were stained with colloidal Coomassie followed by image analysis 
using “Progenesis SameSpots” software (Non Linear Dynamics, Newcastle-Upon-Tyne, 
UK).20 Details on image analysis are reported in Supplementary Methods section. The 
selected bands or spots were identified by MALDI-TOF MS/MS analysis (see in 
Supplementary Methods section for more details).  
Immunoblot analysis and dephosphorylation of blotted proteins 
Proteins were transferred from 1D or 2D gels to membranes for immunoblot analysis and 
probed with specific antibodies as previously described,19,20 see also Supplementary 
Methods for details. Dephosphorylation of blotted proteins was carried out as described in 
Supplementary Methods section.  
Peptides and recombinant  proteins  
The phosphopeptide of band 3 (aa 1-26) and its unphosphorylated analogue were 
synthesized as described previously.25 The recombinant GST-Lyn/SH3 domain was 
expressed and purified according to the protocol described by Trentin et al. 26 The GST-
Lyn/SH2 domain was expressed and purified as previously reported. 27  
Phosphorylation of erythrocyte membranes  
Erythrocyte membranes (3 μg protein) were  phosphorylated for 10 minutes at 30°C in 
30 µL of an incubation mixture containing 50 mM Tris-HCl, pH 7.5, 10 mM MnCl2, 30 µM 
ATP, 200 µM sodium orthovanadate and 15 nM of exogenous Lyn tyrosine kinase, purified 
from rat spleen.27 When required, the phosphorylation assays were carried out in the 
absence or presence of the GST-Lyn/SH2 domain or the GST-Lyn/SH3 domain, 
respectively. The solubilized membranes were analyzed by immuno-blot with the anti- p-
Tyr antibody. The membranes were reprobed with anti-β-actin antibody as a loading 
control. When indicated washed red cells from control and ChAc subjects were incubated 
with and without the Src family kinase inhibitors PP1 (10 μM) and PP2 (10 μM) as 
previously reported.19,27 
Preparation of Syk-phosphorylated membranes of erythrocytes  
Membranes were phosphorylated by 15-nmol/L p36Syk for 10 minutes in 50 mM Tris-HCl, 
10 mM MnCl2, 30μM ATP and 200 μM sodium orthovanadate. Syk-phosphorylated 
membranes  were separated from p36Syk, ATP, and other reagents by centrifugation and 
washed twice as previously reported.27 
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Identification of putative phosphorylation targets of Lyn by sequence and structure 
analyses  
The sequences of the different Tyr-phosphorylated proteins were obtained from the NCBI 
reference sequence database using their accession numbers. They were analyzed by 
means of the GPS 2.0 software to identify putative Lyn target sites.28  Details are reported 
in Supplementary Methods section.  
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RESULTS 
 
Proteomic analysis of ChAc red cell membranes shows differences compared with 
membranes from healthy controls 
Analysis of ChAc red cell membrane proteins by one-dimensional electrophoresis followed 
by protein staining showed that the membrane protein composition of ChAc red cells was 
very similar to that of red cells from healthy controls except for a band at ~ 20 kDa, which 
was markedly reduced in the high density (F2) fraction of red cells of ChAc patients (Fig. 
1b). This band was excised from the gel and identified by mass spectrometry as 
peroxiredoxin-2 (Prx2). Analysis of the red cell membrane protein composition by 
comparative semi-quantitative proteomic approach showed an enrichment in ChAc red cell 
membranes for spectrin and for ankyrin and protein 4.2 major component of the ankyrin 
complex (Supplementary Table 1S). The concentrations of the raft-associated flotillins did 
not differ between control and ChAc samples. However, stomatin, another raft-associated 
protein, was conspicuously enriched in the ChAc samples (Supplementary Table 1S). The 
membrane association of GAPDH was variable with an increase in two out of three ChAc 
patients and a decrease in one ChAc patient (Supplementary Table 1S). In addition, 
proteins of the small G protein family were hardly detectable in the control samples but 
were abundant in the patients’ membrane fractions. All membrane samples contained 
similar amounts of heat shock proteins (data not shown). Immunoblot analysis with specific 
antibodies confirmed: (I) a reduction of membrane associated Prx2 in both low and high 
density fractions of ChAc red cells compared to controls; (II) an increased membrane 
association of GAPDH in the high density fraction of ChAc red cells that were enriched in 
acanthocytes compared to normal controls; (III) a similar membrane content of flotillin 1 in 
ChAc and control red cells (Fig. 1c).  
For a more detailed analysis, we performed two-dimensional electrophoresis (2DE) 
followed by identification of the differently expressed proteins by mass spectrometry. Using 
a twofold abundance as the selection criterion (see also Materials and Methods) we 
detected 50 spots that were differently expressed in high density fraction (F2) of ChAc red 
cells and 41 spots differently expressed in low density fraction (F1) of ChAc red cells (Fig. 
1d, Supplementary Table 2S). It is to be noted that our protein identifications are in strong 
accordance with previously published 2DE maps of red cell membrane.14,20 The identified 
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proteins were divided into eight functional-clusters; (I) proteins of the anchoring 
complexes; (II) cytoskeleton proteins; (III) raft-related proteins; (IV) membrane channels 
and transporters; (V) intracellular signaling proteins; (VI) metabolic enzymes; (VII) proteins 
of the ubiquitin-proteasome system and (VIII) stress response proteins and chaperones.20 
We validated the 2DE data by immunoblot analysis of some of the identified proteins: 
protein p55 in F1 fractionated red cells, flotillin-1 in F1 fractionated red cells and protein 
4.1 in F2 fractionated red cells (Fig. 1e). The differences in membrane and cytoskeleton 
proteins in ChAc red cell observed in 2DE maps were mainly related to protein 2DE 
mobility shift, possibly reflecting protein post-translational modifications (PTMs), such as 
phosphorylation (Fig. 1d-e and Supplementary Table 2S). This is also supported by the 
similar abundancy of membrane and cytoskeleton proteins in 1DE analysis of ChAc and 
control red cell membranes (Fig. 1b).  
Differential extraction of membrane proteins reveals differences in membrane 
organization in ChAc red cells 
In order to explore putative ChAc-associated changes in membrane organization, we 
assessed the strength of binding of the major erythrocyte membrane and cytoskeletal 
proteins to the lipid bilayer by analyzing the proteome following incubation of the 
membrane fractions with 100 mM Na2CO3, pH 11 (see Materials and Methods). In 
controls, this alkaline treatment led to the virtual disappearance of most cytoskeletal and 
membrane-associated proteins such as spectrin, ankyrin, and GAPDH. This was 
accompanied by enrichment of most integral membrane proteins including band 3 and 
Glut1, and by a large increase in the concentration of stomatin (Table 3S). The loss of 
GPC but not GPA suggests that a considerable fraction of the GPC molecules is extracted 
together with the cytoskeleton. As in control samples, extraction of ChAc membranes 
resulted in the depletion of the same proteins as seen  in normal membranes and also in 
enrichment for most integral membrane proteins with band 3 as a notable exception (Table 
3S).  
Since recent studies have suggested that  changes in membrane protein phosphorylation 
state plays an important role in the modulation of red cell membrane protein-protein 
functional cross-talk and stability of multi-protein structures, 29,30 we studied the tyrosine 
(Tyr-) phosphorylation profile of red cell membrane from control and ChAc subjects.  
The tyrosine-phosphorylation state of ChAc red cell membrane proteins is 
increased compared to normal controls 
Evaluation of the Tyr-phosphorylation pattern of red cell membranes from normal and 
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ChAc density-separated red cells by immunoblot analysis showed higher Tyr-
phosphorylation state of various membrane proteins in ChAc red cells (Fig. 2a-b).  
The 2DE Tyr-phospho maps confirmed the presence of trains of Tyr-phosphorylated 
proteins in the gel area corresponding to the differently expressed spots noted in 2DE 
maps: ie.: ankyrin (17-18C  in F1 and 54C-57C and 60C-62C in F2 from ChAc red cells), 
protein 4.1R (21C, 23C, 25 C in F1 and 64C-68C in F2 from ChAc red cells), protein p55 ( 
32C-34C in F1 from ChC red cells) and dematin (88C-89C in F2 from ChAc red cells) (Fig. 
1d and Supplementary Table 2S). These data are also supported by the absence of 
reactivity when the membranes were treated with λ-phosphatase, which was used to 
remove phosphate groups from blotted proteins (Fig. 2a, lower panel). The differently Tyr-
phosphorylated proteins were excised from the 1D stained gels and identified by mass 
spectrometry (Fig. 2b). According to their functions the identified proteins were divided into 
eight functional-clusters: (I) membrane protein, band 3; (II) cytoskeleton network proteins, 
β-spectrin and β-actin; (III) ankyrin complex proteins, ankyrin, band 4.2; (IV) membrane 
junctional complex proteins, band 4.1, p55, β-adducin; (V) intracellular signaling protein; 
(VI) metabolic enzymes such as GAPDH; (VII) stress response proteins such as catalase 
and (VIII) cell trafficking protein such as Ras-related proteins (Table 2). Of note we found a 
Tyr-phosphorylated β-spectrin fragment in both F1 and F2 fractions from ChAc patients 
and we identified a phosphopeptide of β-adducin (R.MLDNLGYR.T) in the dense red cell 
fraction from ChAc subjects (Table 2). These results suggest that altered phosphorylation 
may contribute to acanthocytosis of ChAc.  
Lyn is abnormally activated in ChAc red cells and is independent from Syk 
sequential phosphorylation 
Since Tyr-kinase Syk and the Src family kinase Lyn have been described to be involved in 
modulating band 3 function in healthy red cells,27 we studied membrane association of Syk 
and Lyn in control and ChAc erythrocytes.  
In both F1 and F2 red cells from ChAc patients we observed an increased membrane 
association of active Lyn (phospho-Lyn, Fig. 3a).In contrast, the amount of membrane-
bound total and active Syk (phospho-Syk) was almost undetectable in ChAc and barely 
detectable in control red cells (Fig. 3 a). We previously reported a sequential 
phosphorylation of band 3 catalyzed by the concerted action of Syk and Lyn, with Tyr-8 
and Tyr-21 being first targeted by Syk, and thereby serving  as docking sites for the Src 
homology domain 2 (SH2) of Lyn. Lyn, once recruited, phosphorylates Tyr-359 and Tyr-
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904 of band 327 as well as other proteins  such as spectrins and adducin (unpublished 
data).  
We used specific antibodies against Tyr-8 on the N-terminal of band 3, as a Syk target, 
and Tyr-904 on the trans-membrane domain of band 3, as a Lyn target. We found 
increased Tyr-phosphorylation at Tyr-904 compared to normal red cells (Fig. 3b). 
Phosphorylation of residueTyr-8 was almost absent in both fractions from ChAc red cells 
and only slightly detectable in normal red cells. Since we have previously reported that 
activated Syk might be present in the cytoplasm in a truncated form,21 we evaluated Syk 
activity in the cytoplasm. Syk activity was similar in the cytoplasm of normal and ChAc red 
cells (data not shown), suggesting a peculiar membrane recruitment of Lyn to ChAc 
membranes that occurs independent of preceding phosphorylation of band 3 by Syk.  
To evaluate whether the Tyr-phospho profile of ChAc red cell membrane might be affected 
by in vitro Lyn inhibition, we incubated control and ChAc red cells with both PP1 and PP2, 
Src family kinase inhibitors to obtain a more stable inhibition of kinase activity. As shown in 
Fig. 3c, in ChAc red cells the PP1/PP2 treatment markedly reduced Tyr-phosphorylation 
state of several bands, including band 3, thus supporting the role of Src kinase as 
determinant of the peculiar ChAc red cell membrane Tyr-phosphorylation profile.  
Since the amount of Lyn was markedly higher in ChAc erythrocytes than in control red 
cells, we characterized Lyn red cell membrane association. Lyn was almost entirely 
solubilized by the treatment with Triton-X 100 in both control and ChAc red cells (Fig. 4a, 
lanes 2-3 and 7-8). However, treatment with high ionic strength medium (0.6 M NaCl, see 
Materials and Methods) resulted in a remarkably more extraction of Lyn from ChAc red cell 
membranes compared to that from membranes of control cells, accounting for the 
increased Lyn concentration (Fig. 4a, lanes 4-5 vs 9-10). These data suggest there are 
several pools of Lyn in ChAc red cells, which associate with the membrane by multiple 
modes. This is corroborated by the observation that a fraction of Lyn was released from 
ChAc red cell membranes by agents capable of disrupting the SH2 domain/phospho-Tyr 
interaction, such as GST-Lyn/SH2 and the phosphorylated NH2 terminus of band 3 (Fig. 
4b).  
Exogenous Lyn phosphorylates several targets in ChAC red cell membrane 
independent of Syk  
We then evaluated whether in ChAc red cells the ability of Lyn to phosphorylate red cell 
membrane proteins in vitro was still dependent on a Syk-related mechanism (see above). 
Preparations from control and ChAc red cell membranes were washed free of the 
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phosphatase inhibitor vanadate and resealed  with exogenous Lyn in the presence and 
absence of GST-Lyn/SH2 and GST-Lyn/SH3 domains. Exogenous Lyn was shown to 
phosphorylate ChAc membrane proteins much more efficiently than control fractions (Fig. 
5). In addition, the Tyr-phosphorylation profile remained unaltered in the presence of the 
GST-Lyn/SH3 domain, with only a slight decrease when the GST-Lyn/SH2 domain was 
added (Fig. 5). These data indicate that the ability of Lyn to Tyr-phosphorylate ChAc 
membrane proteins is not dependent on a preceding membrane binding and activity of Syk 
as previously reported for control red cells.27 Thus, ChAc-associated alterations in the 
membrane protein organization may allow Lyn to target its substrates independently from 
Syk. Interestingly, exogenous Lyn promotes Tyr-phosphorylation of membrane proteins 
other than band 3, similarly to that observed in the naturally occurring Tyr-phosphorylation 
profile of ChAc red cell membranes (Fig. 3a and Fig. 5). It is of note that in vitro 
phosphorylation of ChAc red cell membrane by exogenous Lyn involved a smaller number 
of proteins (bands) at molecular weight lower than 48 kDa compared to intact ChAc red 
cells. Otherwise, these proteins showed reduced Tyr-phosphorylation in PP1/PP2 treated 
ChAc red cells, suggesting that Lyn might be also part of other signalling pathways 
involving other kinases or play a role as downstream regulator of phosphatase(s) similarly 
to what we previously described in other red cell models.31,32 
Bioinformatic analysis of the differentially Tyr-phosphorylated proteins reveals Lyn 
targets in ChAc red cells 
To evaluate the presence of possible Lyn targets on ChAc red cell membrane proteins 
differentially Tyr-phosphorylated, we carried out an extensive bioinformatic analysis of 
putative Lyn target sites in the Tyr-phosphorylated proteins identified. This analysis reveals 
that approx. 75% of the proteins has at least one highly Lyn-selective site (Table 3). Only 3 
of them (aldehyde dehydrogenase, carbonic anhydrase and glyceraldehyde 
dehydrogenase) show low specificity (bold) and 2 (stomatin and rab) an even lower 
specificity for Lyn (italic), with increased specificity for other Src kinase members (data not 
shown). Since we found a highly phosphorylated β-spectrin peptide in the proteomic 
analysis and also identified a β-adducin phosphopeptide, we carried out a sequence 
structure analysis of β-spectrin or β-adducin to further characterize the Lyn targets in these 
two proteins. The analysis of the sequence of β-spectrin for Lyn-directed peptides with a 
high threshold score > 2.4 identified five peptides (Table 3, light grey). An intercrossed 
search to identify if these peptides could also serve as substrates for Src tyrosine kinases 
restricted the Lyn-specific target sequences to two tyrosine residues: Tyr-307 and Tyr-
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1590. Inspection of the 3D-structure, indicated that the Tyr-307 is located inside the triplie 
helical bundle, while Tyr-1590 is in the linker region preceding repeat 14, at the interface 
of the ankyrin binding domain (repeats 14-15) 33-35 (Table 3, light grey). The 
phosphopeptide of β-adducin (Tyr-377) is a specific target of Lyn with little specificity for 
Src (Table 3, light grey) and  is located in a highly conserved sequence of the neck 
domain of the protein.36  
Lyn-mediated phosphorylation of ChAc membranes alters the interaction of band 3 
with β-adducin  
We then evaluated the role of Lyn-dependent phosphorylation of band 3 in the interaction 
with β-adducin in ChAc red cells compared to normal erythrocytes. We first 
phosphorylated band 3 by exogenous Syk with or without exogenous Lyn using normal red 
cell membranes, then extracted by Triton-X (Fig. 6a). The immunoprecipitated band 3 from 
the resulting extract was further subjected to immunoblot analysis with anti-adducin 
antibody. As shown in Fig. 6b, in control erythrocytes the presence of β-adducin in the 
band 3 immunoprecipitate was dramatically decreased only if the membranes were 
sequentially phosphorylated by Syk and Lyn. Since in ChAc red cells we have shown band 
3 Tyr-phosphorylated by Lyn independently from Syk phosphorylation, we 
immunoprecipitated band 3 from ChAc extracts and we observed small amount of β-
adducin co-immunoprecipitated, which increased further when membranes were incubated 
in the presence of the Src kinase inhibitor PP2, suggesting that the altered Lyn activity 
was implicated in the mechanism of association between band 3 and β-adducin in ChAc 
red cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 For personal use only. at UNIVERSITAETSSPITAL on November 6, 2011. bloodjournal.hematologylibrary.orgFrom 
 15
DISCUSSION 
 
An integrated proteomic approach enabled us to analyze the perturbation of membrane 
protein organization in ChAc red cells at the molecular level. Our analysis indicated that 
this membrane perturbation mainly affects the multiprotein complexes that anchor the 
cytoskeleton to the membrane through band 3. The ChAc-related alterations in the 
membrane association of GAPDH and hemoglobin also suggest a perturbation of their 
binding sites on band 3. These observations are in agreement with the reduction in 
association of Prx2 with the membrane, that may be due to unavailability of the Prx2 
docking site on band 3, as has also been reported in β-thalassemic red cells.22 These data 
confirm and extend previous observations of neuroacanthocytosis-associated alterations 
on band 310 and extend these to chorea-acanthocytosis specific alterations in band 3 
function. 
Previous studies have shown that Tyr-phosphorylation state of red cell membrane proteins 
is involved in regulation of membrane cohesion and mechanical stability.29 Accordingly, we 
found that several membrane proteins are highly Tyr-phosphorylated in ChAc red cells as 
compared to controls. These proteins are band 3 and other components of the two 
anchoring complexes. Since band 3 is part of both complexes, these findings suggest that 
phosphorylation-induced perturbation of protein-protein interactions may be centered on 
band 3. Changes in the protein phosphorylation state can modify protein-protein 
interactions and thereby multiprotein complex formation and/or functions.37,38  
Previous studies which documented that the Syk-Lyn signaling pathway working in concert 
can modify band 3 function in healthy red cells.27 It is noteworthy that we found increased 
association of active Lyn with the ChAc membranes in the absence of Syk. This is 
surprising, since Syk is responsible for the primary tyrosine phosphorylation of band 3 that 
precedes membrane recruitment of Lyn in normal red cells.27 In ChAc membranes the 
membrane-associated form of Lyn was normally solubilized by detergent but differentially 
partitioned by ionic strength extraction. These data point towards a contribution of 
electrostatic interactions in Lyn binding and suggest the existence of different pools of Lyn 
associated with the membrane. A small amount of Lyn was displaced from the ChAc 
membrane by the addition of GST-Lyn/SH2 or the phosphorylated cytoplasmic domain of 
band 3. This suggests the unmasking of the Lyn domain on band 3, which allows Lyn to 
bind independently from the action of Syk. The conspicuous increase in Tyr-
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phosphorylation state of ChAc red cell membrane proteins by exogenous Lyn supports this 
hypothesis. 
Bioinformatic analyses show that the large part the differentially Tyr-phosphorylated 
proteins identified in ChAc indeed contain Lyn-specific targets or putative Src kinase family 
substrates. In addition, the sequence-structure study allowed us to propose specific Lyn 
phosphorylation sites on β-adducin and β-spectrin, supporting the multi-target action of 
abnormally activated Lyn in ChAc red cells. Notably, Tyr-377 of β-adducin, that is 
phosphorylated in ChAc red cells, is highly conserved.36 This residue is located in the neck 
region that is involved in association of adducin monomers to heterodimers, thereby 
constituting the functionally active form of the protein. This conserved sequence in the 
neck region of adducin is also involved in the organization of an amphiphilic structure, 
which is important in mediating protein-protein interactions.39 In ChAc red cells β-adducin 
was coimmunoprecipitated with band 3 only in presence of the Src kinase inhibitor PP2, 
while in control erythrocyte there was a requirement for sequentially Syk-Lyn band 3 
phosphorylation. Thus, changes in the Tyr-phosphorylation state of β-adducin in this 
region are likely to affect its interactions with the other proteins of the junctional complexes 
and thereby the stability of the red cell membrane protein bridges.  
Our data suggest a novel mechanism in generation of acanthocytes in ChAc in addition to 
what was reported in McLeod syndrome, a neuroacanthocytosis related disorder, and in 
abetalipoproteinemia. In these diseases the acanthocytes formation has been related to 
either the absence of the XK membrane protein convalently linked to the Kell glycoprotein 
and part of the multiprotein 4.1 juctional complex as in McLeod syndrome or to the 
abnormal membrane lipid composition (increased sphingomiein/lecithin ratio) with 
abnormalities of lipid-lipid interaction within membrane as in abetaliproteinemia.40,41 In 
ChAc red cells there is no indication of abnormalities in either membrane lipid composition 
or membrane-and-cytoskeletal protein content. We did, however, find alterations in Tyr-
phosphorylation state of membrane proteins and in signal transduction pathway. Thus, we 
propose that in ChAc red cells the "Lyn storm" might affect the organization of the 
complexes bridging the membrane to the cytoskeleton, most likely by inducing abnormal 
protein interactions through the opening of SH2 binding sites in a Syk-independent 
manner. This might result in the heterogeneous distribution of the cytoskeleton as 
observed in electron microscopy studies,8 and may be similar to the concentration of Lyn 
in plasma membrane patches of activated platelets, adjacent to granules.42,43 In addition, 
abnormal Lyn phosphorylation might also contribute to altered vesiculation of ChAc red 
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cells. Lyn has been found in association with the exosomes that are excreted by 
reticulocytes, containing lipid raft domains, and in vesicles from mature red cells.44-46 
Together with the indication for a stomatin-specific, raft-based process in vesicle formation 
in vitro,47 this supports the hypothesis that vesicle formation is an important, active 
process in the formation of acanthocytes. This is in agreement with increased 
concentrations in ChAc red cell membranes of various small-G-proteins involved in vesicle 
formation and transport.10  
In conclusion, our data link, for the first time, the presence of abnormal red cells in patients 
with ChAC with evidence for an independent and strong Lyn activation. The ChAc-
associated alterations in red cell membrane-protein organization appear to be the result of 
increased Tyr-phosphorylation leading to altered linkage of band 3 to the junctional 
complexes involved in anchoring the membrane to the cytoskeleton. The latter may 
promote an increased degree of freedom of the junctional complexes bridging the 
membrane to the cytoskeleton and affect the association of the cytoskeleton with the 
plasma membrane. The present data open new ways to explore the pathobiology of 
acanthocytes and pathophysiological mechanisms of neurodegeneration in patients with 
neuroacanthocytosis. 
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TABLE 1 
 
 DEMOGRAPHIC AND MOLECULAR DATA OF CONTROL AND  
 CHOREA-ACANTHOCYTOSIS SUBJECTS 
 
 
Gender 
 
Age (yrs) Molecular defect/WB analysis for chorein 
Controls (n=12) 9F/3M 35.6±2.3 - 
ChAc 1 F 35 Intron 3: c.188-5T>G (splice Site); mutation on other 
allele unknown/ nd 
ChAc 2 F 34 nd/ chorein absent 
ChAc 3 F 30 Exon 37: c.4286G>C;p.A1428P; Intron 55: 
c.7806G>A;p.P2602P (splice site)/ chorein absent 
ChAc 4 F 40 Exon 34: c.3889C>T; p.R1297X; Exon 36: 
c.4216del ; p.V1406CfsX20/nd 
ChAc 5 M 47 Intron 22:  c.2288+2T>C; (splice-site mut); Intron 
61: c.8472-1G>C; (splice-site mut)/ nd 
ChAc 6 F 56 (homozygous) Exon 13: c.1115del; p.K372SfsX2/nd 
ChAc 7 M 32 nd/ chorein absent 
ChAc 8 F 38 Intron 6 : c.495+5G>A 
(splice-site mut) Exon 40 : c.4903_4906del ; 
p.K1635VfsX6/ nd 
ChAc 9 F 40 nd/ chorein absent 
 ChAc: chorea-acanthocytosis; WB: Western blot; F: female; M: male; yrs: years; nd: not determined  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 For personal use only. at UNIVERSITAETSSPITAL on November 6, 2011. bloodjournal.hematologylibrary.orgFrom 
 23
 
TABLE 2 
PROTEINS WITH DIFFERENT DEGREES OF TYR-PHOSPHORYLATION IN RED CELL 
MEMBRANES FROM CONTROL AND CHOREA-ACANTHOCYTOSIS SUBJECTS 
 
 
 
The corresponding bands are indicated in Fig. 2b. AC: accession number; PY; tyrosine (Tyr-) phosphorylation. MW: 
molecular weight. The success rate of protein identification by MALDI MS/MS was 82±6.7% (n=9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Band 
#  
AC  Protein  
      
Theorical 
protein MW 
(kDa) 
Matching 
peptide  Coverage %  
1  P11277 Beta spectrin_SPTB1  246.468 146  50  
2  P16157  Ankyrin_ANK1  206.265 20  22  
3  Q8WX82  Beta I spectrin form beta I sigma 3 (fragment)_Q8WX82  
117.549 14  20  
4  P02730  Band 3 anion transport protein_B3AT 101.792 16 18  
5  P02730  Band 3 anion transport protein_B3AT  101.792 23  24  
6  Q9H4B4  Serine threonine protein kinase PLK3_ PLK3  71.629 6  8  
7 P35612 Beta adducin_ADDB 80.854 9 11 
8 P11171  Band 4.1_EPB41  97.017 10  24  
9  P16452  Band 4.2_EPB42  77.009 9  12  
10  Q9H4B4  Serine threonine protein kinase PLK3_ PLK3  71.629 6 11  
11  Q00013  55 kDa erythrocyte membrane protein_EM55  52.296 19  34  
12  Q00013  55 kDa erythrocyte membrane protein_EM55 52.296 6  18  
13 P47895  Aldehyde dehydrogenase family 1 member A3_AL1A3 56.108 3  6  
14  P04040  Catalase_CATA  59.756 4  9  
15 O94921  Serine threonine protein kinase PFTAIRE-1_CDK14  53.057 5  10  
16  Q14012  Calcium calmodulin dependent protein kinase type 1 
_KCC1A 41.337 4  10  
17 P60709  Beta actin_ACTB  41.737 10  34  
18  Q96GD4  Serine threonine protein kinase 12_AURKB  39.311 4  15  
19  P04406  Glyceraldehyde-3-P-dehydrogenase_G3P  36.053 9  36  
20 P27105 Stomatin_STOM 31.731 10 40 
21 P00918  Carbonic Anhydrase 2_CAH2  29.246 3  11  
22 Q96E17  Ras related protein Rab-3C_RAB3C  25.952 3  17  
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TABLE 3 
BIOINFORMATIC ANALYSIS OF THE DIFFERENTLY TYROSINE PHOSPHORYLATED 
PROTEINS IDENTIFIED IN CHOREA-ACANTHOCYTOSIS RED CELLS 
 
# AC Protein Lyn-target Score 
1  P11277 Beta spectrin_SPTB1  
Y-307 
Y-474 
Y-493 
Y-660 
Y-1590 
2.447 
3.596 
3.383 
4.128 
3 
2  P16157  Ankyrin_ANK1  
Y-884 
Y-1468 
Y-1750 
3.83 
2.362 
2.447 
3  Q8WX82  Beta I spectrin form beta I sigma 3 (fragment)_Q8WX82  
Y-307 
Y-474 
Y-493 
Y-660 
Y-1590 
2.447 
3.596 
3.383 
4.128 
3 
4  P027330  Band 3 anion transport protein_B3AT 
Y-8 
Y-21 
Y-46 
Y-359 
Y-904 
8.809 
6.553 
4.149 
4.702 
5.915 
5  P027330  Band 3 anion transport protein_B3AT  
Y-8 
Y-21 
Y-46 
Y-359 
Y-904 
8.809 
6.553 
4.149 
4.702 
5.915 
6  Q9H4B4  Serine threonine protein kinase PLK3_ PLK3  Y-136 2.383 
7 P35612 Beta adducin_ADDB Y-377 0.66 
8 P11171  Band 4.1_EPB41  Y-374 2.489 
9  P16452  Band 4.2_EPB42  Y-435 2.085 
10  Q9H4B4  Serine threonine protein kinase PLK3_ PLK3  Y-136 2.383 
11  Q00013  55 kDa erythrocyte membrane protein_EM55  Y-331 Y-429 
2.468 
2.83 
12  Q00013  55 kDa erythrocyte membrane protein_EM55 Y-331 Y-429 
2.468 
2.83 
13 P47895  Aldehyde dehydrogenase family 1 member A3_AL1A3 Y-497 1.683 
14  P04040  Catalase_CATA  Y-260 1.809 
15 O94921  Serine threonine protein kinase PFTAIRE-1_CDK14  Y-135 4.17 
16  Q14012  Calcium calmodulin dependent protein kinase type 1_ KCC1A 
Y-20 
Y-235 
2.872 
2.723 
17 P60709  Beta actin_ACTB  Y-240 2.702 
18  Q96GD4  Serine threonine protein kinase 12_AURKB  Y-8 2.319 
19  P04406  Glyceraldehyde-3-P-dehydrogenase_G3P  Y-255 1.66 
20 P27105 Stomatin_STOM 
Y-60 
Y-123 
Y-124 
Y-252 
0.213 
0.404 
0.234 
0.426 
21 P00918  Carbonic Anhydrase 2_CAH2  
Y-40 
Y-51 
Y-114 
1.511 
1.745 
1.681 
22 Q96E17  Ras related protein Rab-3C_RAB3C  
Y-17 
Y-29 
Y-50 
Y-92 
Y-99 
Y-100 
Y-110 
Y-131 
0.809 
0.383 
0.298 
0.638 
0.596 
0.638 
0.191 
0.234 
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Light grey refers to identified phosphopeptides of beta-spectrin and beta adducin (see text for details); bold                         
refers to low threshold analysis (see Materials and Methods for details); italic refers to very low threshold            
analysis (see Materials and Methods for details). 
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FIGURE LEGENDS 
 
Fig.1. Proteomic analysis of red cell membrane fractions shows differences in ChAc 
compared to healthy controls. (a) Morphology of red cells from control and chorea-
acanthocytosis (ChAc) subjects. (b-e) Red cells from control (C) and chorea-
acanthocytosis (ChAc) were fractionated in fraction 1 (F1) corresponding to a density < 
1.074, containing reticulocytes, and fraction 2 (F2) corresponding to a density > 1.092, 
containing acanthocytes. (b) The fractionated red cell membrane proteins were separated 
by one-dimensional electrophoresis (1DE) and stained with colloidal Coomassie blue. The 
bands that were identified by mass-spectrometry are indicated: β spectrin (accession 
number:  P11277) 48 % coverage; α spectrin (accession number: P02549) 52 % 
coverage;  band 3 (accession number: P027330) 25% coverage; band 4.1R (accession 
number: P11171) 22 % coverage; band 4.2 (accession: P16452 number) 18 % coverage; 
β-actin (accession number: P60709) 26 % coverage; glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH; accession number: P04406) 18 % coverage; peroxiredoxin 2 
(Prx2; accession number: P32119 ) 32% coverage. The figure shows a representative of 
nine experiments performed with similar results. (c) Western-blot  (Wb) analysis of red cell 
membranes separed by 1DE with specific antibodies against peroxiredoxin 2 (Prx2), 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), flotillin-1 and stomatin proteins of 
fractionated red cells from controls (C) and chorea-acanthocytosis (ChAc) subjects. Actin 
was used as loading control. The data are representative for eight experiments. (d-e) The 
membrane proteins of fractionated red cells (see above and Method section) were 
separated by two-dimensional electrophoresis (2-DE). Twin 2DE gels were run: one 
stained with colloidal Coomassie and the other transferred to membrane for Western-blot 
analysis.  (d) The colloidal Coomassie blue stained gels underwent image analysis and 
differently expressed proteins were identified by mass-spectrometry (see Method  and 
Methods and Supplementary Methods). Red and green spots indicated the differently 
expressed proteins based on image analysis. The identified proteins are reported in Table 
2S. The figures show one representative experiment  from a total eight experiments 
performed. (e) Western-blot (Wb) analysis of the 2DE maps with specific anti- protein p55 
antibody on F1 red cells from control and ChAc subjects (validating the differently 
expressed spots 32C, 33C, 34Ci n Fig. 1d, Table 2S), anti-flotillin-1 antibody on F1 red 
cells from control and ChAc subjects (validating the differently expressed spots 40C in Fig. 
1d, Table 2S), anti-protein 4.1R antibody on F2 red cells from control and ChAc subjects 
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(validating the differently expressed spots 64C-68C in Fig. 1d, Table 2S). The figures show 
one representative experiment of three experiments performed with similar results.  
Fig. 2. Tyrosine phosphorylation of red cell membrane protein is increased in 
chorea-acanthocytosis compared to normal controls. Red cells from control (C) and 
chorea-acanthocytosis (ChAc) subjects were fractionated as described in Materials and 
Methods and in the legend of Fig. 1b-e. Western-blot (Wb) analysis with specific anti-
phosphotyrosine (PY) antibodies of red cell membrane proteins separated by either 
bidimensional electrophoresis (2DE) or monodimensional electrophoresis (1DE). (a) Twin 
2DE gels were run: one used for colloidal Coomassie stained gels (see Fig. 1d) and the 
other for the Western-blot analysis with specific anti-phosphotyrosine (PY) antibodies. 
Upper panel: membranes of high density red cell fraction (F2) from control (C) and 
chorea-acanthocytosis (ChAc) subjects are shown. Similar results were also obtained in 
low density red cell fraction (F1) from control and ChAc (data not shown). Lower panel: 
Dephosphorylation of blotted proteins by recombinant λ protein phosphatase (400 U/mL). 
The blotted membranes were incubated in TBS containing 1% BSA, 0.1 % TRITON X-100, 
2 mM MnCl2 (overnight at 4°C). and then probed with anti-phosphotyrosine antibodies. 
The data are representative for three experiments with similar results. (b) 1DE gels (13 
cm) were blotted for Western-blot (Wb) analysis with specific anti-phosphotyrosine (PY) 
antibodies. The bands with different staining intensities were identified by mass 
spectrometry (Table 2) (see also Materials and Methods section and Supplementary 
Methods). Actin was used as a loading control. The data are representative for eight 
experiments, see also Fig. 1Sb for densitometric analysis of the Tyr-phosphorylation 
profile of the red cell membrane proteins.  
Fig. 3. ChAc red cells show increased Lyn tyrosine kinase associated to the 
membrane. Red cells from control (C) and chorea-acanthocytosis (ChAc) were 
fractionated as described in Materials and Methods and in the legend of Fig. 1b-e. (a) 
Western-blot (Wb) analysis with specific antibodies of membrane associated tyrosine 
kinase Lyn and phospho-Lyn (p-Lyn), Syk and phospho-Syk (p-Syk). Actin was used as a 
loading control. Shown is a representative of six experiments. Vertical line(s) have been 
inserted to indicate a repositioned gel lane. (b) Western-blot analysis with specific 
antibodies against Tyr-8 on the N-terminal of band 3, as a Syk target, and Tyr-904 on the 
transmembrane domain of band 3 (as a Lyn target). We used normal red cells treated with 
Na-vanadate (see Materials and Methods) as positive controls. Total band 3 was used as 
loading control. (c) Western-blot (Wb) analysis with specific anti-phosphotyrosine (PY) 
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antibodies of high density fraction (F2) of red cells from control (C) and chorea-
acanthocytosis (ChAc) subjects are shown. The F2 red cells wre incubated  with or without 
the Src family kinase inhibitors PP1 (10 μM) and PP2 (10 μM) as previously reported.19 
The arrows indicated the bands affected by PP1-PP2 treatment in ChAc red cells 
compared to untreated ChAc red cells. The data are representative for three experiments 
(on 6 cm gels). Actin was used as a loading control. The data are representative for three 
experiments. Similar results were also obtained with cells from low density fraction (F1) 
control and ChAc red cells (data not shown). 
Fig. 4. Modes of interaction of Lyn with membranes from ChAc red cells. (a) 
Membranes of F2 red cells from control (C) and chorea-acanthocytosis (ChAc) subjects 
were extracted with Triton X-100 or NaCl (see Materials and Methods) and assayed after 
ultracentrifugation for the presence of Lyn by Western-blot (Wb) analysis. The data shown 
here are obtained with F2 ChAc red cells. Similar data were obtained with F1 control and 
ChAc red cells (data not shown). (b) Membranes of F2 red cells from control (C) and 
chorea-acanthocytosis (ChAc) subjects were incubated in the presence or absence of 
GST-Lyn/SH3, GST-Lyn/SH2, cdb3 or phospho (p-)-cdb3 and assayed after 
ultracentrifugation for Lyn in the resulting soluble (S) and pellet (P) fractions for the 
presence of Lyn by western-blot (Wb) analysis. Similar data were obtained from F1 control 
and ChAc red cells (data not shown). The membranes were reprobed with anti-actin 
antibody as loading control. 
Fig.5. Phosphorylation patterns of normal and ChAc red cells membranes by 
exogenous Lyn. Membranes of high density fraction (F2) of red cells from control (C) and 
chorea-acanthocytosis (ChAc) subjects were incubated without (lanes 1 and 5), or  with 
exogenous Lyn (lanes 2-4 and 6-8) and with GST-Lyn/SH3 (lanes 3 and 7) or GST-
Lyn/SH2 (lanes 4 and 8), respectively. Samples were then analyzed by Western-blot (Wb) 
analysis with anti-phosphotyrosine antibodies. Similar data were obtained with F1 control 
and ChAc red cells (data not shown). The membranes were reprobed with anti-actin 
antibody as loading control.  
Fig.6. Effect of  phosphorylation of red cells membranes by Syk and/or Lyn on band 
3 binding to β-adducin in normal and ChAc red cell membranes. (a) Membranes 
(lanes 1 and 2), or Syk-phospho-membranes (lanes 3 and 4) of F2 red cells from control 
(C) were incubated without (lanes 1 and 3), or  with exogenous Lyn (lanes 2 and 4) and 
subjected to Western blot analysis with anti-phospho-Tyr (anti-pTyr) antibody (upper 
panel) or were extracted with Triton X-100 and assayed after ultracentrifugation for the 
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presence of band 3 by Western-blot analysis (lower panel). The membranes were 
reprobed with anti-actin antibody as loading control. (b) Band 3 was immunoprecipitated 
from membranes (lanes 1 and 2), and Syk-phospho-membranes (lanes 3 and 4) of F2 red 
cells from C after incubation without (lanes 1 and 3), or  with exogenous Lyn (lanes 2 and 
4). The immunoprecipitates were subjected to Western blot analysis with anti-pTyr (top 
panel), anti-β-adducin antibody. The blots were also probed with anti-band 3 antibody. (c) 
Band 3 was immunoprecipitated from membranes of F2 ChAc red cells previously 
incubated without or with the inhibitor PP2 (10 μM). The immunoprecipitates were 
subjected to Western blot analysis with, anti-β-adducin antibody. The blots were also 
probed with anti-band 3 antibody. The figure is representative of three independent 
experiments. 
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